Thompson et al. subsequently investigated all three chitinases and reported that they were significantly higher in the CSF of ALS patients relative to HCs, mimics, and asymptomatic mutation carriers (MCs) and that increased CHIT1 levels corresponded to active forms of the enzyme. This evidence concerns the gene CHIT1 and amyotrophic lateral sclerosis.